Cancer Treatment News and Research

RSS

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

Scientists have revealed how cancer cells are able to break free of the physical restraints imposed by their surroundings in order to grow and spread around the body.

5 Jan 2017

NSCLC patients treated with surgery may benefit from delayed chemotherapy, study shows

A new study suggests patients who recover slowly from non-small-cell lung cancer (NSCLC) surgery may still benefit from delayed chemotherapy started up to four months after surgery, according to a new study published online by JAMA Oncology.

5 Jan 2017

Yoga during active treatment can provide QOL benefits for pediatric cancer patients and parents

A yoga program for children with cancer can be carried out even during cancer treatment, and has quality of life (QOL) benefits for the children as well as their parents, suggests a study in Rehabilitation Oncology, official journal of the Oncology Section of the American Physical Therapy Association.

5 Jan 2017

Study offers new insights into mechanisms underlying action of motor proteins

A study published today offers a new understanding of the complex cellular machinery that animal and fungi cells use to ensure normal cell division, and scientists say it could one day lead to new treatment approaches for certain types of cancers.

4 Jan 2017

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

The quest to understand a prolonged infection in an infant being treated for leukemia has led to the St. Jude Children's Research Hospital discovery of a mutation that allows bacteria to tolerate normally effective antibiotic therapy. The report appears today in the scientific journal mBio.

3 Jan 2017

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers.

2 Jan 2017

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Human papillomavirus-positive oropharynx cancers (cancers of the tonsils and back of the throat) are on rise.

27 Dec 2016

UCLA-led research finds promising results for more personalized head and neck cancer treatment

Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.

23 Dec 2016

Gene testing could help predict ovarian cancer patients' sensitivity to new class of drugs

Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.

22 Dec 2016

Scientists find explanation for vulnerability of children to collateral damage from cancer treatment

Despite many successes in treating pediatric cancer, young children remain at high risk for developing severe, long-lasting impairments in their brain, heart, and other vital organs from chemotherapy and radiation treatments. In adults, however, these tissues are relatively spared.

22 Dec 2016

Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.

22 Dec 2016

Bioinformatics helps identify new, untested drug combinations for treatment of breast cancer

Based on the study of cell signalling networks, the cell signals that drugs alter when they reach their target molecule, an exhaustive in silico analysis of the pairing of 64 therapeutic agents used to treat breast cancer (half already in use and the other half in clinical testing phase) has allowed researchers at the Institute for Research in Biomedicine to identify 10 new and previously untested combinations that hold potential for the treatment of breast cancer.

20 Dec 2016

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Something as seemingly harmless as a heartburn pill could lead cancer patients to take a turn for the worse.

16 Dec 2016

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).

16 Dec 2016

Study suggests potential blood-based marker to predict oropharyngeal cancer recurrence

A new study suggests the possibility of predicting at its earliest stages when a type of head and neck cancer will come back.

16 Dec 2016

Researchers develop new method to identify antigens for cancer treatment

New cancer therapies harness the immune system to fight tumors. One of the main principles behind these therapies is to find out precisely which molecules on cancer cells trigger an immune response.

16 Dec 2016

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Physical plasma is one of the four fundamental states of matter, together with solid, liquid, and gas, and can be completely or partially ionized (thermal/hot or non-thermal/cold plasma, respectively).

15 Dec 2016

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.

14 Dec 2016

Novel plasma medicine with anti-tumor effect discovered

Nagoya University researchers develop cold plasma-activated Ringer's solution for chemotherapy. The solution has anti-tumor effects in vitro and in vivo that derive from the lactate component.

14 Dec 2016

Cancer Treatment News and Research

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

NSCLC patients treated with surgery may benefit from delayed chemotherapy, study shows

Yoga during active treatment can provide QOL benefits for pediatric cancer patients and parents

Study offers new insights into mechanisms underlying action of motor proteins

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

UCLA-led research finds promising results for more personalized head and neck cancer treatment

Gene testing could help predict ovarian cancer patients' sensitivity to new class of drugs

Scientists find explanation for vulnerability of children to collateral damage from cancer treatment

Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

Bioinformatics helps identify new, untested drug combinations for treatment of breast cancer

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

Study suggests potential blood-based marker to predict oropharyngeal cancer recurrence

Researchers develop new method to identify antigens for cancer treatment

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Novel plasma medicine with anti-tumor effect discovered

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News